Kelsey H Satterly

Title: Kelsey H Satterly: Innovator in Pharmaceutical Delivery Systems

Introduction

Kelsey H Satterly is a notable inventor based in Seattle, WA (US), recognized for his contributions to pharmaceutical delivery systems. With a total of 5 patents, Satterly has made significant advancements in the treatment of various medical conditions through innovative drug delivery methods.

Latest Patents

Satterly's latest patents include groundbreaking methods for the intranasal delivery of olanzapine, aimed at providing acute treatment for agitation in patients with schizophrenia or bipolar disorder. This method involves administering a dry pharmaceutical composition that achieves a mean peak plasma olanzapine concentration of at least 30 ng/mL within less than 0.5 hours. Additionally, he has developed a dry pharmaceutical composition suitable for respiratory tract delivery of levodopa and a dopa decarboxylase inhibitor for the treatment of Parkinson's disease. This composition is designed to enhance the efficacy of treatment for patients suffering from Parkinson's syndrome.

Career Highlights

Throughout his career, Satterly has worked with prominent companies such as Impel Pharmaceuticals Inc. and Impel Neuropharma, Inc. His work in these organizations has contributed to the development of innovative pharmaceutical solutions that address critical health issues.

Collaborations

Satterly has collaborated with notable professionals in the field, including John D Hoekman and Inna Dashevsky, who have played significant roles in his research and development efforts.

Conclusion

Kelsey H Satterly's innovative work in pharmaceutical delivery systems has the potential to transform treatment options for patients with serious medical conditions. His contributions continue to pave the way for advancements in the field of medicine.